Key result
Valsartan suppressed cardiac hypertrophy similarly in wild-type and AT2 null mice, but its inhibitory effects on coronary arterial thickening and perivascular fibrosis were significantly weaker in AT2 null mice.
Why the study?
Does valsartan improve cardiac remodeling after pressure overload via uninhibited AT2 receptor stimulation in mice?
Does valsartan improve cardiac remodeling after pressure overload via uninhibited AT2 receptor stimulation in mice?
The improvement of coronary arterial thickening and perivascular fibrosis by valsartan after pressure overload is partly mediated by uninhibited AT2 receptor stimulation.
Answers are grounded in this paper and cite their sources.
AT2 signaling may partly mediate valsartan's vascular effects in pressure-overloaded mice; leaves open translation to human remodeling.
To clarify the possible involvement of uninhibited angiotensin II (Ang II) type 2 (AT(2)) receptor stimulation in the effects of an Ang II type 1 (AT(1)) receptor blocker, valsartan, we examined the cardiovascular remodeling induced by aortic banding with the use of wild-type (Agtr2+) and AT(2) receptor null (Agtr2-) mice. Aortic banding caused cardiac hypertrophy in Agtr2+ and Agtr2- mice to a similar degree 6 weeks after surgery, whereas coronary arterial thickening and perivascular fibrosis were more exaggerated in Agtr2- mice. The AT(2) receptor was observed predominantly in the coronary arteries and perivascular region of Agtr2+ mice. Valsartan at a dose of 1 mg/kg per day, which did not influence systolic blood pressure, suppressed cardiac hypertrophy similarly in both strains. Valsartan inhibited coronary arterial thickening and perivascular fibrosis in both groups; however, the inhibitory effects of valsartan were significantly weaker in Agtr2- mice. The inhibitory effects of a nonselective Ang II receptor antagonist, [Sar(1),Ile(8)]-Ang II, on cardiac hypertrophy, coronary artery thickening, and perivascular fibrosis were not significantly different in Agtr2+ and Agtr2- mice. These results suggest that the improvement by valsartan of coronary arterial thickening and perivascular fibrosis after pressure overload is caused by uninhibited AT(2) receptor stimulation in addition to AT(1) receptor blockade.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2002) studied Cardiovascular remodeling induced by aortic banding. Valsartan vs. Wild-type vs AT2 null mice was evaluated on Cardiac hypertrophy, coronary arterial thickening, and perivascular fibrosis. Valsartan suppressed cardiac hypertrophy similarly in wild-type and AT2 null mice, but its inhibitory effects on coronary arterial thickening and perivascular fibrosis were significantly weaker in AT2 null mice.
Synapse has enriched 10 related papers. Consider them for comparative context: